Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
10,244
datasets available to search
ShareScore release 0.9.0
Dataset results
10,244 results for “Vaccine”
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
ClinicalTrials.gov study NCT02747927. IPD Sharing: YES. Countries: 8. Publications: 8.
Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines, Given in a Pre-exposure Regimen to Children and Adults and as Single Booster Dose to a Subset of Adults
ClinicalTrials.gov study NCT04127786. IPD Sharing: YES. Countries: 1. Publications: 1.
Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines
ClinicalTrials.gov study NCT03104075. IPD Sharing: YES. Countries: 1. Publications: 2.
A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1)
ClinicalTrials.gov study NCT04830800. IPD Sharing: NO. Countries: 1. Publications: 1.
B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B
ClinicalTrials.gov study NCT04193189. IPD Sharing: YES. Countries: 10. Publications: 3.
Study Describing the Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a Licensed Quadrivalent-inactivated Influenza Vaccine (IIV4) (Fluarix® Quadrivalent) in Parti
ClinicalTrials.gov study NCT05144945. IPD Sharing: YES. Countries: 1. Publications: 1.
Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose
ClinicalTrials.gov study NCT01439165. IPD Sharing: YES. Countries: 2. Publications: 2.
SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine
ClinicalTrials.gov study NCT04952402. IPD Sharing: YES. Countries: 1. Publications: 0.
Immunogenicity and Safety of a Purified Vero Rabies Vaccine
ClinicalTrials.gov study NCT03145766. IPD Sharing: YES. Countries: 1. Publications: 1.
Promoting Altruism to Enhance Vaccine Acceptance
ClinicalTrials.gov study NCT04568590. IPD Sharing: YES. Countries: 1. Publications: 1.
Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup
ClinicalTrials.gov study NCT04084769. IPD Sharing: YES. Countries: 2. Publications: 1.
Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults
ClinicalTrials.gov study NCT03965962. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America
ClinicalTrials.gov study NCT01374516. IPD Sharing: YES. Countries: 5. Publications: 15.
Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age
ClinicalTrials.gov study NCT03698279. IPD Sharing: YES. Countries: 2. Publications: 1.
Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®
ClinicalTrials.gov study NCT02993757. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia
ClinicalTrials.gov study NCT01373281. IPD Sharing: YES. Countries: 5. Publications: 20.
Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
ClinicalTrials.gov study NCT02948829. IPD Sharing: YES. Countries: 2. Publications: 1.
Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Taiwanese Adult
ClinicalTrials.gov study NCT04537234. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety of Dengue Vaccine in Healthy Children
ClinicalTrials.gov study NCT00842530. IPD Sharing: YES. Countries: 1. Publications: 6.
Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older
ClinicalTrials.gov study NCT04537208. IPD Sharing: YES. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.